For the President to maintain popularity and be humankind’s hero, he must deploy the vaccine for most of the world without a hitch.
With little hope for the amateur spy, a federal agent then tries to turn a Genyologen employee into an asset.
The espionage has brought suspicion from the outset. Under test, the inside agent must find a cure before he succumbs to the deadly virus.
Corporate spy, Ray Zy-Dyent, interviews at a major pharmaceutical competitor to access incriminating evidence for the government.
The government recruits a scientist to go undercover as a spy to gather information about a serum to cure the rampant disease.
The largest pharma-tech company weighs the advantages of a consortium to battle a global health crisis.
A major entity within the pharmaceutical consortium discusses ramifications of the Presidents’s international speech.
Premiere: As the year 2100 approaches, this world teeters on the edge of a new era—or human extinction in this novella miniseries.
Featured authors and reviewers
This information does not constitute professional medical care or legal advice. Discuss personal concerns with your doctor or legal advisor.